Stock listing
NASDAQ:DRMA Dermata Therapeutics, Inc. Stock
Home listing (NASDAQ) of Dermata Therapeutics, Inc.
Follow Dermata Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:DRMA
$0.775 USD -0.066 (-7.9%)
Close on Oct 30, 2026
- Day range
- $0.764 – $0.829 USDOct 30, 2026
- Volume
- 61,673 sharesOct 30, 2026
- Market cap
- $3.84M USDAt the close on Oct 30, 2026 · price × 4.96M shares outstanding
- 52-week range
- $0.603 – $4.660 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $3.24M USDMedian day 61,687 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:DRMA · Home | $0.775 USD | -0.066 (-7.9%) | 61,673 | $0.799 | $0.829 | $0.764 | $0.841 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:DRMA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.775 | -0.066 | -7.9% | $0.799 | $0.829 | $0.764 | 61,673 | |
| $0.841 | -0.034 | -3.8% | $0.880 | $0.880 | $0.823 | 31,522 | |
| $0.875 | +0.120 | +15.9% | $0.770 | $0.890 | $0.750 | 169,729 | |
| $0.755 | +0.037 | +5.2% | $0.736 | $0.770 | $0.673 | 186,890 | |
| $0.718 | -0.063 | -8.1% | $0.765 | $0.780 | $0.703 | 114,084 | |
| $0.781 | -0.083 | -9.6% | $0.833 | $0.850 | $0.772 | 119,400 | |
| $0.864 | +0.064 | +8.0% | $0.780 | $0.870 | $0.780 | 137,700 | |
| $0.800 | -0.070 | -8.0% | $0.850 | $0.890 | $0.782 | 221,200 | |
| $0.870 | +0.010 | +1.2% | $0.855 | $0.928 | $0.830 | 181,000 | |
| $0.860 | 0.000 | 0.0% | $0.848 | $0.970 | $0.760 | 851,500 | |
| $0.860 | -0.050 | -5.5% | $0.909 | $0.950 | $0.810 | 2,517,700 | |
| $0.910 | +0.247 | +37.3% | $0.769 | $1.180 | $0.766 | 170,521,300 | |
| $0.663 | -0.197 | -22.9% | $0.860 | $0.860 | $0.603 | 350,800 | |
| $0.860 | -0.030 | -3.4% | $0.890 | $0.900 | $0.840 | 38,100 | |
| $0.890 | -0.130 | -12.7% | $1.000 | $1.010 | $0.887 | 39,600 | |
| $1.020 | -0.050 | -4.7% | $1.080 | $1.080 | $1.010 | 22,100 | |
| $1.070 | -0.050 | -4.5% | $1.100 | $1.100 | $1.050 | 7,000 | |
| $1.120 | -0.010 | -0.9% | $1.140 | $1.140 | $1.110 | 7,400 | |
| $1.130 | +0.020 | +1.8% | $1.120 | $1.145 | $1.110 | 29,600 | |
| $1.110 | +0.005 | +0.5% | $1.160 | $1.160 | $1.090 | 14,100 | |
| $1.105 | -0.005 | -0.5% | $1.160 | $1.160 | $1.080 | 17,600 | |
| $1.110 | +0.010 | +0.9% | $1.080 | $1.130 | $1.060 | 20,800 | |
| $1.100 | -0.030 | -2.7% | $1.100 | $1.120 | $1.100 | 14,700 | |
| $1.130 | +0.010 | +0.9% | $1.120 | $1.175 | $1.115 | 10,400 | |
| $1.120 | -0.020 | -1.8% | $1.140 | $1.160 | $1.100 | 25,000 | |
| $1.140 | -0.030 | -2.6% | $1.150 | $1.200 | $1.130 | 30,300 | |
| $1.170 | +0.050 | +4.5% | $1.150 | $1.250 | $1.120 | 78,100 | |
| $1.120 | -0.030 | -2.6% | $1.180 | $1.180 | $1.120 | 14,400 | |
| $1.150 | 0.000 | 0.0% | $1.170 | $1.190 | $1.150 | 25,800 | |
| $1.150 | -0.010 | -0.9% | $1.150 | $1.180 | $1.140 | 19,700 | |
| $1.160 | 0.000 | 0.0% | $1.180 | $1.190 | $1.140 | 5,600 | |
| $1.160 | +0.010 | +0.9% | $1.120 | $1.200 | $1.120 | 14,300 | |
| $1.150 | +0.020 | +1.8% | $1.110 | $1.174 | $1.100 | 25,700 | |
| $1.130 | -0.020 | -1.7% | $1.160 | $1.187 | $1.060 | 36,900 | |
| $1.150 | -0.040 | -3.4% | $1.180 | $1.270 | $1.150 | 17,700 | |
| $1.190 | -0.010 | -0.8% | $1.230 | $1.230 | $1.160 | 24,900 | |
| $1.200 | -0.010 | -0.8% | $1.210 | $1.225 | $1.180 | 16,400 | |
| $1.210 | -0.040 | -3.2% | $1.240 | $1.280 | $1.210 | 18,400 | |
| $1.250 | +0.040 | +3.3% | $1.220 | $1.312 | $1.210 | 51,100 | |
| $1.210 | -0.020 | -1.6% | $1.230 | $1.259 | $1.201 | 40,300 | |
| $1.230 | -0.050 | -3.9% | $1.280 | $1.369 | $1.210 | 101,900 | |
| $1.280 | -0.020 | -1.5% | $1.310 | $1.310 | $1.250 | 53,400 | |
| $1.300 | +0.010 | +0.8% | $1.270 | $1.310 | $1.250 | 17,400 | |
| $1.290 | -0.050 | -3.7% | $1.300 | $1.330 | $1.270 | 61,700 | |
| $1.340 | -0.120 | -8.2% | $1.470 | $1.580 | $1.340 | 103,400 | |
| $1.460 | -0.150 | -9.3% | $1.590 | $1.590 | $1.460 | 88,000 | |
| $1.610 | -0.110 | -6.4% | $1.700 | $1.720 | $1.590 | 75,000 | |
| $1.720 | +0.090 | +5.5% | $1.650 | $1.720 | $1.500 | 194,600 | |
| $1.630 | +0.210 | +14.8% | $1.430 | $1.630 | $1.410 | 214,000 | |
| $1.420 | +0.040 | +2.9% | $1.380 | $1.470 | $1.360 | 229,800 | |
| $1.380 | -0.090 | -6.1% | $1.490 | $1.490 | $1.360 | 99,200 | |
| $1.470 | +0.040 | +2.8% | $1.450 | $1.580 | $1.420 | 143,900 | |
| $1.430 | -0.030 | -2.1% | $1.420 | $1.470 | $1.400 | 141,600 | |
| $1.460 | 0.000 | 0.0% | $1.450 | $1.550 | $1.300 | 230,700 | |
| $1.460 | -0.110 | -7.0% | $1.470 | $1.550 | $1.400 | 421,600 | |
| $1.570 | +0.190 | +13.8% | $1.210 | $1.620 | $1.180 | 1,289,000 | |
| $1.380 | +0.300 | +27.8% | $1.260 | $1.460 | $1.190 | 16,783,300 | |
| $1.080 | -0.040 | -3.6% | $1.095 | $1.110 | $1.080 | 23,098,000 | |
| $1.120 | +0.020 | +1.8% | $1.100 | $1.120 | $1.060 | 26,200 | |
| $1.100 | -0.010 | -0.9% | $1.180 | $1.180 | $1.090 | 72,100 | |
| $1.110 | -0.060 | -5.1% | $1.170 | $1.180 | $1.080 | 80,400 | |
| $1.170 | +0.070 | +6.4% | $1.130 | $1.205 | $1.110 | 64,200 | |
| $1.100 | +0.025 | +2.3% | $1.090 | $1.170 | $1.070 | 47,000 | |
| $1.075 | -0.095 | -8.1% | $1.190 | $1.200 | $0.951 | 220,600 | |
| $1.170 | -0.010 | -0.8% | $1.190 | $1.218 | $1.150 | 83,700 | |
| $1.180 | 0.000 | 0.0% | $1.190 | $1.200 | $1.160 | 45,400 |
- Ticker
- NASDAQ:DRMA
- Asset type
- Stock
- Sector
- Consumer goods
- Industry
- Household & personal care
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial
Latest news
Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial
Oct 29, 2026
Closed $0.775 (-7.9%) on Oct 30, 2026
Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
Oct 15, 2026
Closed $0.91 (+37.3%) on Oct 15, 2026
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
Aug 25, 2026
Closed $1.72 (+5.5%) on Aug 25, 2026
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Aug 17, 2026
Closed $1.46 (0.0%) on Aug 17, 2026
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
Aug 11, 2026
Closed $1.38 (+27.8%) on Aug 12, 2026
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
Aug 5, 2026
Closed $1.17 (+6.4%) on Aug 5, 2026
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
May 13, 2026
Closed $1.23 (+3.4%) on May 14, 2026
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
Apr 2, 2026
Closed $1.29 (+7.5%) on Apr 2, 2026
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
Mar 26, 2026
Closed $1.37 (-6.2%) on Mar 26, 2026
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
Mar 10, 2026
Closed $1.27 (-4.5%) on Mar 10, 2026
Financings
Private placement of shares of common stock (or pre-funded warrants) with series E and series F warrants
Aug 17, 2026
Announced: about US$3.4M · US$1.46 a share · Warrants at US$1.46
Insiders: Company insiders, including the CEO, CFO and a member of management, are participating at $1.47 per share and accompanying warrants, with warrant exercise price of $1.47
Use of proceeds: General corporate purposes incl. consumer research, launch of direct-to-consumer product, acquisitions, licensing and working capital
Decks
IPO Roadshow (July 2021)
IPO roadshow · 31 slides · Jul 12, 2021
Dermata Therapeutics, Inc. on 6ix
- Sector
- Consumer goods
- Industry
- Household & personal care
- News releases
- 15 in the last 12 months · 88 in all · newest Oct 29, 2026 · oldest 2021
- Decks
- 1 deck · latest Jul 12, 2021
Where Dermata Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:DRMA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:DRMA | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Dermata Therapeutics, Inc.